HIV/AIDS

Funding Opportunities for HIV/AIDS Researchers

NIAID funds HIV/AIDS research through a variety of mechanisms. The following is a description of the various grant programs available to investigators interested in pursuing specific types of HIV/AIDS studies.

Grant Program	Description	Area of HIV/AIDS Research
Basic Research on HIV Persistence	Supports the development of new ideas and approaches to understand persistent HIV infection in patients on highly active anti-retroviral therapy (HAART) and to develop strategies to control and eliminate the virus-carrying cells.	Basic Research
Novel HIV Therapies: Integrated Preclinical/Clinical Program (IPCP)	Supports research by collaborative groups seeking to transition from preclinical to clinical studies, as well as pilot clinical studies of novel HIV treatments. This program is designed to promote creative and original therapeutic research on diverse facets of HIV infection between multidisciplinary preclinical and clinical research groups from academic, nonprofit institutions and research firms.	Treatment
Small Business Innovative Research (SBIR)	Grants that provide incentive for biotechnology industry studies of targeted therapies and drug delivery systems.	Treatment
Basic HIV Vaccine Discovery Research	Supports the identification of new concepts and approaches and use of previously successful infectious disease approaches to design a preventive HIV vaccine.	Basic Research, Treatment, Vaccine
Phased Innovation Awards (PIA)	Funds exploratory projects as a way to bring new concepts into the vaccine research and development "pipeline."	Vaccine
HIV Vaccine Research and Design (HIVRAD)	Grant program designed to advance concepts toward the development of a prophylactic AIDS vaccine.	Vaccine
Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD)	Cooperative agreement program that supports HIV/AIDS vaccine concept refinement and testing, culminating in human clinical trials.	Vaccine
HIV Vaccine Design and Development Teams (HVDDT)	Five-year contracts designed to fund a focused team of scientists from industry and/or academia to advance a mature, promising therapeutic vaccine concept and a plan for targeted development and clinical evaluation (Phase I/II trials).	Vaccine, Basic Research
Highly Innovative Tactics to Interrupt Transmission of HIV (HIT-IT)	Grants to fund novel scientific approaches for providing long-term protection from HIV infection.	Vaccine
HIV Proteins and Their Cellular Binding Partners	Grant program designed to support studies that are particularly innovative, novel, possibly high risk/high impact and that have potential to advance understanding of the interactions of HIV proteins with cellular binding partners.	Vaccine
Centers for AIDS Research (CFARs)	Provides administrative and shared research support for high-quality AIDS research projects through core facilities that provide expertise, resources, and services not otherwise readily obtained through more traditional funding mechanisms.	Basic Research
HIV Interdisciplinary Network for Pathogenesis Research in Women	Seeks applications from institutions to participate in a multidisciplinary pathogenesis research program to investigate HIV transmission, disease acquisition, progression, and manifestations of HIV in women.	Basic Research, Epidemiology
Microbicide Innovation Program	A milestone-driven program that supports focused microbicide innovation and development.	Prevention, Microbicide
Integrated Preclinical Clinical Program for HIV Topical Microbicides	Program designed to support preclinical discovery and development leading up to exploratory Phase I clinical trials aimed at advancing a candidate microbicide or strategy to more advanced clinical trials.	Prevention, Microbicide
Microbicide Design and Development Teams (PDF)	Program that supports microbicide development from initial discovery through exploratory clinical testing (Phase I studies).	Prevention, Microbicide

More information on current funding opportunities.

back to top